Division of Neurology, Department of Internal Medicine, Ditmanson Medical Foundation, Chia-Yi Christian Hospital, Chiayi City, Taiwan; Min-Hwei College of Health Care Management, Tainan, Taiwan.
J Neurol Sci. 2013 Dec 15;335(1-2):96-100. doi: 10.1016/j.jns.2013.08.036. Epub 2013 Sep 3.
Stroke vascular territories may influence response to thrombolysis, although supporting data are limited. The aim of the study was to test the hypothesis that the current available prediction scores might inaccurately estimate the risk of symptomatic intracerebral hemorrhage (SICH) after intravenous thrombolysis in patients with posterior circulation stroke.
We applied the Safe Implementation of Thrombolysis in Stroke (SITS) SICH risk score to data from four hospital-based stroke registries. Patients were grouped according to anterior or posterior circulation stroke. The main outcome measure was SICH per various definitions. Performance of the risk score was assessed with the c statistic.
Data of 518 thrombolyzed patients (434 anterior, 84 posterior) were studied. The overall rate of SICH varied from 3.5% to 6.9% depending on the SICH definition. Patients with posterior circulation stroke were less likely to have post-thrombolysis SICH per NINDS (P=0.042), per ECASS II (P=0.013), or any ICH (P=0.001), and their rate of SICH was markedly lower than predicted (1.2% versus 7.1% by the NINDS definition; 0% versus 4.8%, ECASS II; 0% versus 1.6%, SITS-MOST). The SITS SICH risk score shows moderate model discrimination across the SICH definitions, with c statistic ranging from 0.64 to 0.70.
The risk of SICH after intravenous thrombolysis in patients with posterior circulation stroke was low enough to render the SITS SICH risk score or other similar prediction models unnecessary. Awareness of stroke territory might help clinicians judiciously use the risk assessment models.
尽管有一些支持性的数据,但卒中血管分布区域可能会影响溶栓治疗的效果。本研究旨在验证以下假说:目前的预测评分可能无法准确评估后循环卒中患者接受静脉溶栓治疗后发生症状性颅内出血(SICH)的风险。
我们将 Safe Implementation of Thrombolysis in Stroke(SITS)SICH 风险评分应用于四项基于医院的卒中登记研究的数据中。根据前循环或后循环卒中对患者进行分组。主要观察指标是各种定义下的 SICH。采用 c 统计量评估风险评分的性能。
共纳入了 518 例接受溶栓治疗的患者(前循环 434 例,后循环 84 例)。根据 SICH 的不同定义,总体 SICH 发生率为 3.5%至 6.9%。后循环卒中患者发生溶栓后 SICH 的可能性更小,NINDS 定义(P=0.042)、ECASS II 定义(P=0.013)或任何 ICH 定义(P=0.001)均如此,且实际 SICH 发生率明显低于预测值(NINDS 定义下为 1.2%对 7.1%;ECASS II 定义下为 0%对 4.8%;SITS-MOST 定义下为 0%对 1.6%)。SITS SICH 风险评分在不同 SICH 定义下的模型区分度中等,c 统计量范围为 0.64 至 0.70。
后循环卒中患者接受静脉溶栓治疗后发生 SICH 的风险足够低,因此无需使用 SITS SICH 风险评分或其他类似的预测模型。了解卒中分布区域可能有助于临床医生明智地使用风险评估模型。